Status:
RECRUITING
Pulse Study: Peripheral Use of Low-dose Vasopressors for Safety and Efficacy in the Intensive Care Unit
Lead Sponsor:
Kingston Health Sciences Centre
Conditions:
Shock
Peripheral Venous Catheterization
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Using medications to increase blood pressure, called vasopressors, is invaluable in treating patients who have difficulty maintaining stable blood pressure. Vasopressors are usually infused through a ...
Detailed Description
In the intensive care unit (ICU), vasopressors are administered when fluid resuscitation alone cannot maintain adequate blood pressure in patients with shock. The standard of care for continuous infus...
Eligibility Criteria
Inclusion
- Adults aged 18 or older who do not have a central line or PICC line already placed
- Presence of shock requiring vasopressors at the following minimum doses: norepinephrine 5 mcg/min, phenylephrine 50 mcg/min, epinephrine 5 mc/min, dobutamine 5 mcg/kg/min
Exclusion
- Urgent need for dialysis requiring placement of hemodialysis catheter
- More than two vasopressors are required to maintain a MAP \>65 on admission to the ICU
- Pregnancy or suspected pregnancy
Key Trial Info
Start Date :
February 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06920173
Start Date
February 3 2025
End Date
June 30 2026
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston Health Sciences Center
Kingston, Ontario, Canada, K7K 2V7